1 study found for:    22873531 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: CP 690,550;   Drug: CP-690,550;   Other: Placebo;   Biological: Biologic TNFi

Indicates status has not been verified in more than two years